News & events Upcoming events MEDICA Nov 18, 2019 - Nov 21, 2019 Düsseldorf , Germany More info and meet us there LXXI Reunión Anual de la Sociedad Española de Neurología (SEN) Nov 19, 2019 - Nov 23, 2019 Sevilla , Spain More info and meet us there 51° Congresso Nazionale Sibioc Nov 20, 2019 - Nov 22, 2019 Padova , Italy More info and meet us there See all upcoming events Latest news Fujirebio Europe announces CE marking of the Lumipulse® G CK-MB assay, used to aid in the diagnosis of Acute Myocardial Infarction (AMI) Oct 13, 2017 Fujirebio Europe today announced the CE marking of the Lumipulse G CK-MB immunoassay, which can be used as an aid in the diagnosis of Acute... Read more Morphotek®, Inc. Announces an Agreement With Fujirebio Diagnostics, Inc to commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab® Sep 5, 2017 Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it entered into a collaboration and license agreement with Fujirebio... Read more Fujirebio Europe announces the CE-marking of the Lumipulse® G Total Tau assay and extends its offer of fully automated assays aiding in the early diagnosis of Alzheimer’s disease Jul 16, 2017 Fujirebio Europe today announced the CE-marking of the Lumipulse G Total Tau assay for its fully automated LUMIPULSE immunoassay systems.... Read more Fujirebio Europe launches Lumipulse® G HTLV-I/II for fully automated screening of HTLV-I/II viral infection Apr 5, 2017 Fujirebio Europe today announced the release of Lumipulse G HTLV-I/II, a CE-marked CLEIA (chemiluminescent enzyme immunoassay) test kit for... Read more Fujirebio Europe launches the Lumipulse® G hs Troponin I and Lumipulse G Myoglobin immunoassays for both the LUMIPULSE G1200 and G600II platforms Mar 27, 2017 Fujirebio Europe has announced the release of the Lumipulse G hs Troponin I assay for use in the diagnosis of Acute Myocardial Infarction... Read more Fujirebio Europe launches Lumipulse® G β-Amyloid 1-42, a fully automated assay aiding in the early diagnosis of neurodegeneration Jan 23, 2017 Fujirebio Europe today announced the release of the Lumipulse G β-Amyloid 1-42 assay for its fully automated LUMIPULSE immunoassay systems.... Read more Load More
LXXI Reunión Anual de la Sociedad Española de Neurología (SEN) Nov 19, 2019 - Nov 23, 2019 Sevilla , Spain More info and meet us there
51° Congresso Nazionale Sibioc Nov 20, 2019 - Nov 22, 2019 Padova , Italy More info and meet us there
Fujirebio Europe announces CE marking of the Lumipulse® G CK-MB assay, used to aid in the diagnosis of Acute Myocardial Infarction (AMI) Oct 13, 2017 Fujirebio Europe today announced the CE marking of the Lumipulse G CK-MB immunoassay, which can be used as an aid in the diagnosis of Acute... Read more
Morphotek®, Inc. Announces an Agreement With Fujirebio Diagnostics, Inc to commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab® Sep 5, 2017 Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it entered into a collaboration and license agreement with Fujirebio... Read more
Fujirebio Europe announces the CE-marking of the Lumipulse® G Total Tau assay and extends its offer of fully automated assays aiding in the early diagnosis of Alzheimer’s disease Jul 16, 2017 Fujirebio Europe today announced the CE-marking of the Lumipulse G Total Tau assay for its fully automated LUMIPULSE immunoassay systems.... Read more
Fujirebio Europe launches Lumipulse® G HTLV-I/II for fully automated screening of HTLV-I/II viral infection Apr 5, 2017 Fujirebio Europe today announced the release of Lumipulse G HTLV-I/II, a CE-marked CLEIA (chemiluminescent enzyme immunoassay) test kit for... Read more
Fujirebio Europe launches the Lumipulse® G hs Troponin I and Lumipulse G Myoglobin immunoassays for both the LUMIPULSE G1200 and G600II platforms Mar 27, 2017 Fujirebio Europe has announced the release of the Lumipulse G hs Troponin I assay for use in the diagnosis of Acute Myocardial Infarction... Read more
Fujirebio Europe launches Lumipulse® G β-Amyloid 1-42, a fully automated assay aiding in the early diagnosis of neurodegeneration Jan 23, 2017 Fujirebio Europe today announced the release of the Lumipulse G β-Amyloid 1-42 assay for its fully automated LUMIPULSE immunoassay systems.... Read more
